Azzet reports on three stocks with price moving updates today.
4DMedical rockets on Mayo Clinic update ~
Shares in 4DMedical (ASX: 4DX) were trading 32% higher by 1:10 pm AEDT (2:10 am GMT) after the Melbourne-based respiratory imaging technology company told the market that its CT:VQ airflow and blood flow imaging technology has been deployed at the Mayo Clinic in the United States.
Given that it’s widely regarded as one of the world's leading hospitals, Mayo Clinic’s deployment of CT:VQ is seen as a major expansion of its footprint across leading U.S. academic medical centres.
Mayo Clinic is the sixth major U.S. institution to adopt CT:VQ, following deployments at Stanford, Cleveland Clinic, UC San Diego Health, University of Chicago Medicine and University of Miami.
Focussed on integrating the technology into clinical workflows and allowing clinicians to evaluate its capabilities across a range of use cases, the initial 90-day agreement will support clinical integration and evaluation of the technology, with potential to transition to full commercial terms.
Commenting on today’s update, management told the market that, despite being immaterial financially, the Mayo Clinic is expected to act as a key reference site to support broader uptake.
The company’s CEO, Andreas Fouras, described the Mayo Clinic's adoption - one of the most significant endorsements of its technology to date - as a landmark moment for 4DMedical and a powerful testament to the clinical significance of our technology.
“No other technology in our space has achieved this level of clinical adoption in such a short timeframe,” said Fouras.
“When the world's number one hospital chooses to use your technology, it sends the strongest possible signal to the entire U.S. healthcare market about the clinical value and readiness of CT:VQ.”
To accelerate the commercialisation of CT:VQ, 4DMedical (ASX: 4DX) raised $150 million from institutional investors back in January.
The institutional placement was priced at $3.80 per share - a discount to the company’s closing price on 14 January of $4.29 per share.
4DMedical Limited has a market cap of $3.6 billion; the share price is up 1,702% in one year and up 68% in the last week.
While the stock’s 200-day moving average is trending upwards and highlights long-term investor interest in the stock, the 20-day moving average is falling as upwards momentum wanes.
Consensus is Moderate Buy.
Amplitude Energy tanks on 2nd consecutive drilling failure
Shares in Amplitude Energy (ASX: AEL) - formerly Cooper Energy - fell 36.4%, touching fresh two-year lows after the energy company told the market that its Isabella gas discovery in the offshore Otway Basin was non-commercial following flow test results.
Given that pressure depletion during the testing period does not support a commercial development of the Isabella field – marking its second consecutive drilling failure in the ECSP sequence - the well will now be plugged and abandoned.
Today’s update follows revelations that Elanora-1, drilled in January 2026 and targeting the Waarre A reservoir, was found to be water-bearing rather than gas-bearing, and this triggered a 20% fall at the time.
Commenting on today’s update, Amplitude CEO Jane Norman told investors that the result at Isabella is disappointing, but geological data from this well will help inform future exploration prospects.
“Isabella was a large and prospective target for the ECSP; however, its size also corresponded with reservoir complexity, meaning it will require time to interpret the drilling information received,” she said.
“The result at Isabella does not impact our view on the probability of success of other Otway Basin exploration prospects, which have simpler geology.”
On a more positive note, the company reminded the market that its East Coast Supply Project (ECSP) plans remain unchanged.
The drilling program remains within budget, with the ASX 300 Energy stock expecting the next well to be drilled in the second half of calendar year 2026.
While a final investment decision (FID) for the development phase of the ECSP has been deferred until after the new wells are drilled, the company is still targeting first gas from the project in 2028.
Amplitude Energy is targeting first gas from the project in 2028.
The company’s balance sheet and cash position have not changed materially with this announcement, and the existing producing assets continue to generate operating cashflows.
While the ECSP growth project is clearly not an existential one for this stock, it was the primary reason the market gave Amplitude a growth premium.
That premium has now been substantially removed, and investors now appear to be repricing the Final Investment Decision (FID) timeline.
While ECSP is Amplitude’s flagship project, the company also has production operations in the Gippsland Basin (Offshore Victoria), Otway Basin (Offshore Victoria), and Cooper Basin (Onshore South Australia).
In FY25, the company recorded trailing twelve-month revenue of approximately $275 million with underlying profitability still narrow.
Amplitude Energy has a market cap of $494 million; the share price is down 30% in one year and down 38% in the last week.
The stock’s shares appear to be in a near-term downtrend confirmed by its 20-day moving average.
Consensus is Strong Buy.
Greenwing Resources jumps after flagging mining restart
Shares in Greenwing Resources (ASX: GW1) were trading 7.7% higher at noon after the critical minerals explorer/developer told the market it had launched a Pre-Feasibility Study (PFS) at its 100%-owned Que River polymetallic project in Tasmania to refine the scale, economics and development pathway for a potential restart of mining.
Built on earlier scoping studies and an updated mineral resource estimate, the PFS aims to clarify mine design, processing options, costs, approvals and environmental and rehabilitation parameters.
It’s understood that the miner is pursuing a two-stage strategy that initially targets low-capex open pit mining of about 660,000 tonnes of gold, copper, silver, zinc and lead-bearing material using third-party processing, then evaluates longer-term data infrastructure opportunities on site.
Previous analysis suggested a roughly 40% uplift in net smelter return and conceptual cash flows to around $100 million.
Greenwing is also advancing lease renewal, rehabilitation planning, stakeholder engagement and potential strategic partnerships to unlock broader value from the Que River to host data infrastructure.
The miner hopes to leverage the site’s existing infrastructure, strategic location, and favourable characteristics, including proximity to a 30MW substation, 200ML of water availability, cleared areas, established access, and a remote, secure location.
The company will update the market on the PFS progress and related developments in due course.
Beyond Tasmania, Greenwing (formerly Bass Metals Limited) has lithium and graphite projects across Madagascar and Argentina and plans to supply electrification markets, while researching and developing advanced materials and products.
In late 2022, Chinese EV maker NIO invested $12 million to become Greenwing’s largest shareholder, securing a potential joint venture and offtake partner for its San Jorge Lithium Project in Argentina.
Greenwing Resources has a market cap of $19 million; the share price is up 19% in one year and down 10% in the last week.
While the stock's 200-day moving average is trending upwards and highlights long-term investor interest in the stock, the 5-day moving average is below the 20-day moving average.
Consensus does not cover this stock.
This article does not constitute financial or product advice. You should consider independent advice before making financial decisions.
